WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013153479) INDOLE AND INDAZOLE COMPOUNDS THAT ACTIVATE AMPK
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/153479    International Application No.:    PCT/IB2013/052604
Publication Date: 17.10.2013 International Filing Date: 01.04.2013
IPC:
C07D 403/12 (2006.01), C07D 401/14 (2006.01), C07D 405/14 (2006.01), C07D 413/14 (2006.01), A61K 31/404 (2006.01), A61K 31/416 (2006.01), C07D 231/56 (2006.01), C07D 401/04 (2006.01), C07D 401/12 (2006.01), C07D 405/12 (2006.01), C07D 413/12 (2006.01), C07D 209/42 (2006.01), A61P 3/04 (2006.01), A61P 35/00 (2006.01), A61P 3/10 (2006.01)
Applicants: PFIZER INC. [US/US]; 235 East 42nd Street New York, New York 10017 (US)
Inventors: BHATTACHARYA, Samit Kumar; (US).
CAMERON, Kimberly O'Keefe; (US).
DOWLING, Matthew Scott; (US).
EBNER, David Christopher; (US).
FERNANDO, Dilinie Prasadhini; (US).
FILIPSKI, Kevin James; (US).
KUNG, Daniel Wei-Shung; (US).
LEE, Esther Cheng Yin; (US).
SMITH, Aaron Christopher; (US).
TU, Meihua Mike; (US)
Agent: KLEIMAN, Gabriel L.; Pfizer Inc. 235 East 42nd. Street New York, New York 10017 (US)
Priority Data:
61/622,129 10.04.2012 US
Title (EN) INDOLE AND INDAZOLE COMPOUNDS THAT ACTIVATE AMPK
(FR) COMPOSÉS D'INDOLE ET D'INDAZOLE QUI ACTIVENT L'AMPK
Abstract: front page image
(EN)The present invention relates to indole and indazole compounds of Formula (I) that activate 5' adenosine monophosphate-activated protein kinase (AMPK). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of AMPK.
(FR)Cette invention concerne des composés d'indole et d'indazole de Formule (I) qui activent la protéine kinase activée par le 5' adénosine monophosphate (AMPK). Cette invention concerne également des compositions pharmaceutiques contenant lesdits composés et des méthodes destinées à traiter ou à prévenir des maladies, des affections, ou des troubles améliorés par activation de l'AMPK.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)